Aeglea BioTherapeutics, Inc. (AGLE) Stock Price

10.57 ▲ +0.855 (+8.80%)
Open: 10.11 Vol: 192.18K Day's range: 10.11 - 10.60 May 25, 15:40 EDT
IEX Real-Time Price
Free Stock Screener
Loading chart ...
AGLE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 10.45▲ 10.42▲ 10.34▲ 10.07▲ 9.98▲
MA10 10.15▲ 9.99▲ 9.97▲ 10.35▲ 9.68▲
MA20 9.90▲ 9.92▲ 10.01▲ 10.11▲ 8.34▲
MA50 9.98▲ 10.20▲ 10.41▲ 9.61▲ 5.94▲
MA100 10.25▲ 10.37▲ 10.26▲ 8.06▲ 5.83▲
MA200 10.41▲ 9.93▲ 9.50▲ 6.19▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.117▲ 0.134▲ 0.115▲ -0.050▼ N/A    
RSI 71.353▲ 64.918▲ 61.224▲ 59.197▲ N/A    
STOCH 99.435▲ 95.047▲ 80.001▲ 32.916     67.049    
WILL %R -2.362▲ -2.362▲ -2.362▲ -31.868     -11.813▲
CCI 105.466▲ 123.870▲ 132.129▲ 35.494     72.859    
Latest Filters Detected On AGLE
RSI $AGLE RSI(14) Crossed Above 50 Set Alert
MA $AGLE Price Crossed Above MA(13) Set Alert
MA $AGLE Price Crossed Above MA(7) Set Alert
▲ GAP $AGLE Open Gap Up %3 Set Alert
▲ GAP $AGLE Open Gap Up %2 Set Alert
CDL $AGLE Marubozu Candlestick Pattern Detected Set Alert
Aeglea BioTherapeutics, Inc. News
Aeglea BioTherapeutics to Present at UBS Global Healthcare Conference
Tuesday, May 15, 2018 06:13 AM
Company to Webcast Presentation on Tuesday, May 22 at 8:30 a.m. ET AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme ...
Avid's (AVID) CEO Jeff Rosica on Q1 2018 Results - Earnings Call Transcript
Thursday, May 10, 2018 08:52 PM
Avid Technology, Inc. (NASDAQ:AVID) Q1 2018 Results Earnings Conference Call May 10, 2018 5:00 PM ET Executives Dean Ridlon - VP, IR Jeff Rosica - President and CEO Brian Agle - SVP and CFO Analysts Steve Frankel - Dougherty Hamed Khorsand - BWS Financial ...
Benzinga Pro's 5 Stocks To Watch Today
Tuesday, April 24, 2018 10:23 AM
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) gained more than 7 percent after receiving favorable coverage from a Wall Street analyst. Evercore ISI initiated coverage of the clinical-stage biotechnology that focuses on treatments for rate genetic diseases ...
AGLE historical stock data
date open high low close volume
25/05/18 10.11 10.60 10.11 10.57 192,182
24/05/18 9.96 10.01 9.33 9.715 218,316
23/05/18 9.94 10.5608 9.8325 9.89 146,182
22/05/18 10.31 10.43 9.82 9.99 107,475
21/05/18 10.53 10.53 10.20 10.20 108,025
18/05/18 10.86 10.86 10.61 10.61 93,859
17/05/18 10.63 10.84 10.61 10.755 121,312
16/05/18 10.78 11.15 10.56 10.79 268,752
15/05/18 10.29 10.84 10.16 10.67 275,039
14/05/18 9.81 10.66 9.81 10.32 357,933
Quote Details
Bid:10.57
Ask:0.00
52wk Low:2.81
52wk High:11.15
Vol:192.18K
Avg Vol(3m):3.6M
1Y Chng:+89.77%
1M Chng:+15.65%
Add to Watch List
More Information
Sector N/A
Index NASDAQ Composite
Market Cap. 212.47M